Cognixion
Cognixion is a neurotechnology company that develops advanced brain-computer interface (BCI) platforms integrated with augmented reality (AR) to enable communication and interaction for people with complex disabilities. Their flagship product, the Cognixion ONE Axon-R, is a wearable, wireless headset combining EEG, AR, and AI technologies to provide research-quality physiological data and immersive neurophysiology experiences. The device supports multi-modal sensor fusion, no-code SDK for easy app development, and robust software integration, targeting researchers and institutions for diverse neurophysiological studies. Cognixion also offers Speakprose 3, an AAC app with predictive keyboard and Alexa integration for personalized communication. The company operates on a SaaS and device sales model, serving academic and commercial research markets, and is recognized with multiple awards and patents in natural user interfaces and BCI for AR. Cognixion is headquartered in the USA and Canada, focusing on accessibility and innovation in neurotech.
Cognixion
Cognixion is a neurotechnology company that develops advanced brain-computer interface (BCI) platforms integrated with augmented reality (AR) to enable communication and interaction for people with complex disabilities. Their flagship product, the Cognixion ONE Axon-R, is a wearable, wireless headset combining EEG, AR, and AI technologies to provide research-quality physiological data and immersive neurophysiology experiences. The device supports multi-modal sensor fusion, no-code SDK for easy app development, and robust software integration, targeting researchers and institutions for diverse neurophysiological studies. Cognixion also offers Speakprose 3, an AAC app with predictive keyboard and Alexa integration for personalized communication. The company operates on a SaaS and device sales model, serving academic and commercial research markets, and is recognized with multiple awards and patents in natural user interfaces and BCI for AR. Cognixion is headquartered in the USA and Canada, focusing on accessibility and innovation in neurotech.